BR112021019104A2 - Micropartículas secas - Google Patents
Micropartículas secasInfo
- Publication number
- BR112021019104A2 BR112021019104A2 BR112021019104A BR112021019104A BR112021019104A2 BR 112021019104 A2 BR112021019104 A2 BR 112021019104A2 BR 112021019104 A BR112021019104 A BR 112021019104A BR 112021019104 A BR112021019104 A BR 112021019104A BR 112021019104 A2 BR112021019104 A2 BR 112021019104A2
- Authority
- BR
- Brazil
- Prior art keywords
- dry microparticles
- pharmaceutical compositions
- microparticles
- dry
- slow
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000004005 microsphere Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
micropartículas secas. a presente invenção é dirigida a composições farmacêuticas e, em particular, a composições farmacêuticas de liberação lenta compreendendo microesferas poliméricas carregadas com molécula de anticorpo, na forma de micropartículas secas. as micropartículas secas e as composições farmacêuticas que compreendem as referidas micropartículas secas são estáveis durante a fabricação e durante o armazenamento e demonstram características interessantes de liberação lenta. além disso, a invenção se refere a métodos para preparar as referidas micropartículas secas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1906835.2A GB201906835D0 (en) | 2019-05-15 | 2019-05-15 | Dry microparticles |
PCT/EP2020/063326 WO2020229536A1 (en) | 2019-05-15 | 2020-05-13 | Dry microparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112021019104A2 true BR112021019104A2 (pt) | 2021-11-30 |
Family
ID=67384654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021019104A BR112021019104A2 (pt) | 2019-05-15 | 2020-05-13 | Micropartículas secas |
Country Status (13)
Country | Link |
---|---|
US (1) | US20220211627A1 (pt) |
EP (1) | EP3968958A1 (pt) |
JP (1) | JP2022533038A (pt) |
KR (1) | KR20220008853A (pt) |
CN (1) | CN113811292A (pt) |
AU (1) | AU2020275908A1 (pt) |
BR (1) | BR112021019104A2 (pt) |
CA (1) | CA3135455A1 (pt) |
GB (1) | GB201906835D0 (pt) |
IL (1) | IL287984A (pt) |
MX (1) | MX2021013796A (pt) |
SG (1) | SG11202110933YA (pt) |
WO (1) | WO2020229536A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022111547A1 (en) * | 2020-11-24 | 2022-06-02 | The University Of Hong Kong | Inhaled powder formulations for respiratory delivery of antibodies |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5997856A (en) | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
WO1999061062A1 (en) * | 1998-05-29 | 1999-12-02 | Massachusetts Institute Of Technology | Cyclodextrin complexes |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
EP1980853A1 (en) * | 2007-04-11 | 2008-10-15 | Alfresa Pharma Corporation | Method of preventing precipitation of a reactive substance-bound microparticle, and reagent containing the micro particle |
WO2014151725A1 (en) * | 2013-03-14 | 2014-09-25 | Allergan, Inc. | Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process |
GB201411320D0 (en) | 2014-06-25 | 2014-08-06 | Ucb Biopharma Sprl | Antibody construct |
CN108938600B (zh) * | 2018-07-11 | 2021-10-08 | 南京锐利施生物技术有限公司 | 玻璃体内注射的对抗体药物双重保护的微球及其制备方法 |
-
2019
- 2019-05-15 GB GBGB1906835.2A patent/GB201906835D0/en not_active Ceased
-
2020
- 2020-05-13 CN CN202080034816.XA patent/CN113811292A/zh active Pending
- 2020-05-13 EP EP20725709.8A patent/EP3968958A1/en active Pending
- 2020-05-13 KR KR1020217039975A patent/KR20220008853A/ko active Search and Examination
- 2020-05-13 WO PCT/EP2020/063326 patent/WO2020229536A1/en unknown
- 2020-05-13 BR BR112021019104A patent/BR112021019104A2/pt unknown
- 2020-05-13 US US17/595,176 patent/US20220211627A1/en active Pending
- 2020-05-13 AU AU2020275908A patent/AU2020275908A1/en active Pending
- 2020-05-13 MX MX2021013796A patent/MX2021013796A/es unknown
- 2020-05-13 JP JP2021565947A patent/JP2022533038A/ja active Pending
- 2020-05-13 CA CA3135455A patent/CA3135455A1/en active Pending
- 2020-05-13 SG SG11202110933YA patent/SG11202110933YA/en unknown
-
2021
- 2021-11-10 IL IL287984A patent/IL287984A/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20220008853A (ko) | 2022-01-21 |
IL287984A (en) | 2022-01-01 |
WO2020229536A1 (en) | 2020-11-19 |
AU2020275908A1 (en) | 2021-11-04 |
GB201906835D0 (en) | 2019-06-26 |
SG11202110933YA (en) | 2021-10-28 |
EP3968958A1 (en) | 2022-03-23 |
MX2021013796A (es) | 2021-12-10 |
CA3135455A1 (en) | 2020-11-19 |
CN113811292A (zh) | 2021-12-17 |
JP2022533038A (ja) | 2022-07-21 |
US20220211627A1 (en) | 2022-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2541428T3 (es) | Dispositivo para su uso en la manipulación de una carga y procedimiento para fabricar un dispositivo de este tipo | |
CO6660512A2 (es) | Proceso para fabricar composiciones hemostáticas secas y estables | |
EA201490178A1 (ru) | Стабилизированные композиции для местного применения, содержащие микрокапсулы с ядром и оболочкой | |
BR112015032340A2 (pt) | composições e artigos para cuidados pessoais | |
CL2019001486A1 (es) | Emulsión cera-extensor orgánico y método para la fabricación de la misma. | |
CL2012002695A1 (es) | Articulo para fumar, que comprende una primera parte que contiene una fuente de material para fumar y una segunda parte que tiene al menos un extremo que esta configurado para desplazarse en relacion con la primera parte, en donde el articulo ademas comprende un agente modificador de humo que se libera en el articulo para fumar; y envase. | |
ES2646037T3 (es) | Composiciones de acabado, sustratos recubiertos y métodos relacionados | |
BR112015003093A8 (pt) | composições melhoradas de partículas substancialmente esféricas | |
CY1121942T1 (el) | Συνθεσεις που σχηματιζουν κελυφος για μαλακες καψουλες και μαλακες καψουλες | |
BR112013020404A2 (pt) | formulações de l-mentol multiparticulado e métodos relacionados | |
CR20150604A (es) | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos | |
CR20150588A (es) | Métodos y composiciones para matriz de polímero sintetizada por policondensación | |
BR112015016734A2 (pt) | composições estabilizadas compreendendo ácido hialurônico | |
RS54584B1 (en) | 15-HEPE PREPARATIONS AND PROCEDURES FOR THEIR USE | |
PE20151759A1 (es) | Imidazopiridazinas sustituidas | |
AR095672A1 (es) | Composiciones farmacéuticas que comprenden everolimus | |
BR112014013149A2 (pt) | peça moldada, material granular, método para produzir um material granular e uso de uma peça moldada | |
BR112021019104A2 (pt) | Micropartículas secas | |
BR112016014673A2 (pt) | Composição espumável, processos para a fabricação de uma composição e de um material de espuma, material de espuma, e, artigo | |
UY35848A (es) | Tienopirimidinas | |
BR112016022749A2 (pt) | compostos de azole substituído por amido como inibidores de tnks1 e/ou tnks2 | |
BR112015024348A2 (pt) | composições farmacêuticas de tansulosina ou sais destas | |
BR112021019612A2 (pt) | Formulações, recipiente, artigo de fabricação, método para produzir a formulação e método para inibir a agregação de uma proteína presente em uma solução aquosa | |
BR112014008527A2 (pt) | núcleo absorvente | |
UY37444A (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |